Literature DB >> 3106413

Attempted reduction of Abbott MS-2 false-susceptible errors for cefotaxime-resistant Pseudomonas aeruginosa by medium modification.

D W Lander, D L Jungkind, L L Stone.   

Abstract

Thirty-five modifications of Abbott MS-2 growth medium were evaluated in an attempt to reduce the high frequency of false-susceptible errors produced by the MS-2 system when testing resistant Pseudomonas aeruginosa against cefotaxime. A hypotonic modification with 0.1% KNO3 reduced the errors from 41 to 20% for 23 resistant isolates. All hypertonic modifications proved unsatisfactory. No modification reduced false-susceptible errors to acceptable clinical levels.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3106413      PMCID: PMC266070          DOI: 10.1128/jcm.25.4.732-733.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  The release and characterization of some periplasm-located enzymes of Pseudomona aeruginosa.

Authors:  A R Bhatti; I W DeVoe; J M Ingram
Journal:  Can J Microbiol       Date:  1976-10       Impact factor: 2.419

2.  Osmotically induced changes of cell spaces in Neisseria meningitidis competence variants.

Authors:  K Jyssum
Journal:  Acta Pathol Microbiol Scand B       Date:  1976-02

3.  Plasmolysis during the division cycle of Escherichia coli.

Authors:  A J Olijhoek; C G Van Eden; F J Trueba; E Pas; N Nanninga
Journal:  J Bacteriol       Date:  1982-10       Impact factor: 3.490

4.  Comparative antipseudomonal activity of some newer beta-lactam agents.

Authors:  D Greenwood; A Eley
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

Review 5.  Clinical microbiology of unusual Pseudomonas species.

Authors:  A von Graevenitz
Journal:  Prog Clin Pathol       Date:  1973

6.  In vitro activity of furazlocillin (Bay k 4999) compared with those of mezlocillin, piperacillin, and standard beta-lactam antibiotics.

Authors:  T D Gootz; C C Sanders; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1979-06       Impact factor: 5.191

7.  False-susceptible results from the MS-2 system used for testing resistant Pseudomonas aeruginosa against two third-generation cephalosporins, moxalactam and cefotaxime.

Authors:  L L Stone; D L Jungkind
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

8.  In vitro susceptibility of Pseudomonas species to carbenicillin and trimethoprim-sulfamethoxazole.

Authors:  S F Hill; D J Haldane; J H Ngui-Yen; J A Smith
Journal:  J Clin Microbiol       Date:  1985-09       Impact factor: 5.948

  8 in total
  1 in total

Review 1.  Cefotaxime. An update of its pharmacology and therapeutic use.

Authors:  P A Todd; R N Brogden
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.